Skip to content Skip to navigation

The Addiction Psychologist Podcast

Dr. Noah Emery and Samuel Acuff interview researchers, clinicians, and policymakers in the field of addiction psychology with the hopes of enhancing recovery. New episodes the second Monday of every month, with some added content in between. The podcast can also be accessed through Apple podcasts and Spotify. Official podcast of the Society for Addiction Psychology. Transcripts of each episode can be found by clicking here


Dr. David Eddie - Brain-Body Connections

posted: Monday, January 17, 2022 - 08:14

Alcohol use produces changes in the cardiovascular system affecting heart rate. These systematic differences in heart rate can, in turn, function as a biological signature (i.e., biomarker) of dysfunction among those with alcohol use disorder (AUD). In addition to assessing difficulties, understanding heart rate modulation may have important treatment implications. Dr. David Eddie talks about heart rate variability as a biomarker of AUD and his work developing behavioral skills that can target heart rate using biofeedback to improve AUD treatment outcomes. Dr. Eddie is an Assistant Professor at Harvard Medical School and a Research Scientist at both Massachusetts General Hospital’s Center for Addiction Medicine and Recovery Research Institute.

Dr. Matthew Johnson - Psychedelics: History and Therapeutic Value

posted: Monday, December 6, 2021 - 12:09

Most commonly known psychedelics are considered schedule 1 substances by the controlled substances act, meaning they is no currently accepted medical use and a high potential for abuse. However, there is emerging evidence that psychedelics may have some therapeutic value. Dr. Matthew Johnson discusses the history of psychedelic research in the United States and his work on understanding abuse potential and therapeutic value of one specific psychedelic, psilocybin. Matt is the Susan Hill Ward Professor in Psychedelics and Consciousness and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins.

Dr. Robert Miranda - Treating Substance Use Disorder in Adolescence

posted: Monday, November 8, 2021 - 10:13

A great deal of our research focuses on adults with substance use disorder. Yet, many who develop severe substance use disorder begin during adolescence. What types of psychosocial treatments are available for adolescents? What about pharmacological treatments? Does combining psychosocial and pharmacological treatments increase efficacy? In this episode, Dr. Robert Miranda discusses treatments available for adolescents and the complications of developing these treatments. Dr. Robert Miranda is a Professor of Psychiatry and Human Behavior in the Warren Alpert Medical School, a Professor of Behavioral and Social Sciences in the School of Public Health, and the Training Director of the NIAAA/NIDA Postdoctoral Fellowship in the Center for Alcohol and Addiction Studies at Brown University. He is also the Clinical Director of the Vista Intensive Outpatient Program at Bradley Hospital in Providence, Rhode Island.

Policy Brief: Dr. Adam Leventhal Discusses the FDA Authorization of the Marketing of Three New E-Cigarette Products

posted: Thursday, October 21, 2021 - 08:18

On this new Addiction Psychologist segment, we talk to experts about new policy developments to get a better understanding of the implications for our work, our clients, and our personal lives. On this episode, we talk with Dr. Adam Leventhal about the October 12, 2021 announcement that the FDA has authorized the marketing of three new tobacco products, marking the first set of electronic nicotine delivery system (ENDS) products ever to be authorized by the FDA through the Premarket Tobacco Product Application (PMTA) pathway. Dr. Adam Leventhal is a Professor in the Department of Preventive Medicine and Psychology in the Keck School of Medicine at the University of Southern California and a member of the Tobacco Products Scientific Advisory Committee for the Food and Drug Administration.

You can read the full FDA press release here. In the days after the recording of this episode, the FDA made a similar announcement authorizing several oral tobacco products, suggesting that authorizations may occur at a rapid pace in the coming weeks. 

Dr. Hollis Karoly - Cannabinoids in Cannabis: CBD and THC

posted: Monday, October 18, 2021 - 11:20

Cannabis is becoming increasingly tolerated, both culturally and legally, across the United States and other parts of the world. Yet, there are at least 100 different psychoactive cannabinoids in any strain of cannabis. What do we know about these cannabinoids? Dr. Hollis Karoly talks about the two most common cannabinoids, THC and CBD, and what the scientific evidence suggests about their harms and benefits. She then discusses the connection between cannabinoids and alcohol use. Dr. Hollis Karoly is an Assistant Professor in the Department of Psychology at Colorado State University.

Follow Us

Facebook IconTwitter Icon